The advancements in cardiovascular regenerative medicine are reshaping therapeutic strategies for heart diseases by promoting tissue repair and regeneration. This innovative field leverages technologies such as induced pluripotent stem cells and growth factor delivery to restore the heart’s structural and functional integrity. Bioengineered scaffolds and 3D bioprinting are also being utilized to reconstruct damaged myocardium and improve vascularization. Researchers are further exploring the role of exosomes and microRNAs in enhancing the heart’s natural regenerative processes. With ongoing clinical trials and interdisciplinary collaboration, cardiovascular regenerative medicine holds immense potential to provide long-term solutions for conditions like ischemic heart disease and heart failure, moving beyond traditional treatments toward curative approaches.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with Major Adverse Cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical School, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt
Title : Successful treatment of sinus of valsalva aneurysm
Aina Jarillo, Universidad Anahuac Mexico Norte, Mexico
Title : Metabolic and echocardiographic predictors of ventricular extrasystoles burden in non-ischemic patients
Ahmed Ahmed Mohamed Hassan, Al-Azhar Medical School, Egypt
Title : Young hearts at risk: Hidden cardiovascular damage and the role of social determinants of health among youth with type 1 diabetes in Kenya
Phoebe Wamalwa, Ministry of Health, Kenya